表紙
市場調查報告書

非處方藥、醫療設備、診斷藥物:全球市場

OTC Drugs, Medical Devices and Diagnostics: Global Markets

出版商 BCC Research 商品編碼 941891
出版日期 內容資訊 英文 317 Pages
訂單完成後即時交付
價格
非處方藥、醫療設備、診斷藥物:全球市場 OTC Drugs, Medical Devices and Diagnostics: Global Markets
出版日期: 2020年06月05日內容資訊: 英文 317 Pages
簡介

全球的非處方藥、醫療設備、診斷藥物市場規模在2019∼2024年間預測達到6.9%CAGR的成長,從2019年2590億美金成長到2024年3610億美金的規模。

本報告是針對全球的OTC (over the counter) 藥品、醫療設備、診斷藥物市場分析並提供產品的概要與市場的基本構成 (包含成為對象的主要疾病與障礙等)、現在的市場範圍和未滿足的需求、市場規模與成長率的動向預測、主要影響市場成長因素、現在的研究開發與資本的動向與前景、法規環境、未來市場成長的可能性與方向性、主要企業概說等情報資訊。

第1章 導論

第2章 摘要重點

第3章 成為對像主要疾病與障礙

  • OTC對像主要疾病與障礙:概要
    • 心血管疾病
    • 與生活方式有關的疾病
    • 呼吸系統疾病
    • 肌肉骨骼疾病
    • 精神/情緒障礙
    • 胃腸道疾病
    • 泌尿外科疾病
    • 慢性傷口
    • 慢性疼痛
    • 恐慌症/焦慮症
    • 耳鼻喉科(ENT)疾病
    • 牙齒疾病
    • 飲食失調
  • 吸煙及相關疾病
  • 慢性病:擴大OTC市場的範圍
  • 衰老/性別與疾病發作
    • 全球人口統計
    • 美國人口統計
    • 美國:性別、年齡、平均壽命
    • 歐洲人口統計
    • 日本人口統計
  • 現在的課題與未來的方向性

第4章 OTC藥品和膳食補充劑

  • OTC治療藥物概要
  • OTC醫藥品進化
  • 藥物與臨床的必要
  • 以藥物為主的疾病管理
    • 通用名藥物與疾病管理
    • 通用名藥物與專利藥物
    • 對於通用名藥物的抵抗感
  • OTC醫藥品與種類
    • OTC止痛藥/退燒藥
    • OTC抗組胺藥、止咳藥、感冒藥
    • OTC胃腸藥
    • OTC皮膚藥
    • OTC口腔護理產品
    • OTC眼部護理產品
    • OTC禁煙產品
  • 主要已經問世的OTC醫藥品
  • OTC膳食補充劑及其類型
    • 進食障礙
    • 維生素和礦物質缺乏症的治療
    • 維生素/礦物質補充劑(VMS)
  • OTC的銷售渠道
    • 各國OTC醫藥品生產商
    • 藥妝店與其他連鎖店
    • 日用消費品(FMCG)
  • OTC醫藥品購買情況
  • 法規對OTC醫藥品市場的影響
  • OTC醫藥品與膳食補充劑的市場情況
    • 發達市場
    • 發展中國家市場
    • 不發達的市場
  • 治療和成本負擔
  • 未滿足的需求
  • 當前問題和未來發展

第5章 OTC醫療設備、診斷藥物

  • 醫療設備、診斷、疾病管理
  • OTC醫療設備、診斷藥物:臨床現場與市場的必要
  • OTC醫療設備、診斷藥物種類
    • 自我治療設備和可穿戴設備
    • 診斷設備/套件
  • 主要產品
    • 診斷/監控裝置
    • 處理設備及技術
  • 遠程病人監護和家庭護理
  • 數字化治療疾病管理的好處
  • 未滿足的需求
  • 當前問題
  • 未來展望

第6章 用於治療依從性 (Adherence) 的OTC設備

  • 不遵守治療規定
  • OTC製藥粘附設備市場需求
  • 以硬件為中心的OTC藥物附著裝置
    • 智能藥瓶
    • 自動藥片分配器
    • 電子托盤
    • 智能藥丸蓋
    • 其他依從性設備和解決方案
  • 主要產品
    • 智能藥丸分配器、藥丸盒、整理器、智能藥丸蓋、藥瓶系統
    • 其他OTC附件設備
  • 現在課題
  • 未來展望

第7章 市場規模與成長分析

  • 市場規模與成長率分析
    • 市場規模與成長率分析:按地域區別
    • 市場規模與成長率分析:按產品區別
    • 市場規模與成長率分析:按疾病種類區別
  • 促進與阻礙市場成長因素
  • 法規對OTC市場的影響
  • 歐洲的OTC市場對Brexit的影響
  • OTC市場SWOT分析

第8章 OTC藥、醫療設備、診斷藥物市場的競爭情況

  • 競爭情況:OTC藥、醫療設備、診斷技術區別的疾病治療與管理

第9章 OTC藥、醫療設備、診斷藥物市場的戰略

  • OTC醫藥品與醫療設備市場的企業重組
  • 非處方藥、醫療設備、診斷藥物市場的企業合併收購 (M&A)
  • 至今的M&A
  • 未來戰略前景

第10章 法規結構:藥、醫療設備、診斷藥物

  • 法規背景
  • 醫療設備的法規:按地域區別
    • 美國
    • 歐洲
    • 日本
  • 醫藥品的法規制度:按地域區別
  • OTC醫藥品膳食補助劑的法規與規定

第11章 價格與報銷:藥、醫療設備、診斷藥物

  • 價格/醫療費用報銷的背景
  • 醫療器械價格/醫療費用報銷:按地域區別
  • 醫藥品價格/醫療費用報銷:按地域區別

第12章 結論:非處方藥、醫療設備、診斷藥物市場的未來前景

  • 影響市場的主要動向
    • 技術開發
    • 人口和經濟趨勢
    • 醫療行業的結構變化
    • 生活方式醫學
    • 以患者為中心的計劃
    • 自我保健的普遍性
    • 公共衛生系統的負擔
    • 保持市場領先地位
  • 長期展望

第13章 企業概要

  • 3M
  • ABBOTT LABORATORIES
  • ABBVIE INC.
  • ACADIA PHARMACEUTICAL
  • ACORDA THERAPEUTICS
  • ACTAVIS PLC
  • ACTUALMEDS
  • ADHERIUM
  • AETHLON MEDICAL INC.
  • AGENUS
  • AKRON
  • ALACER CORP.
  • ALCON INC.
  • ALERE INC.
  • ALFRESA PHARMA CORP.
  • ALIPHCOM INC.
  • ALIVECOR
  • ALKALON A/S
  • ALKERMES
  • ALLERGAN
  • ALLIANCE HEALTHCARE
  • AMGEN INC.
  • AMIKO
  • AMNEAL PHARMACEUTICALS
  • ANAVEX LIFE SCIENCES
  • ANI PHARMACEUTICALS
  • ANIMAS (JOHNSON & JOHNSONソ子會社)
  • APOTEX
  • ARCHOS
  • ARENA PHARMACEUTICALS
  • ARRAY BIOPHARMA
  • 旭化成
  • ASLAN PHARMACEUTICALS
  • ASPEN PHARMACARE
  • ASSERTIO THERAPEUTICS, INC.
  • Astellas Pharma
  • ASTRAZANECA PLC
  • ATHERSYS
  • AUDENTES THERAPEUTICS
  • AXIOBIONICS
  • AXSOME THERAPEUTICS
  • BAUSCH & LOMB
  • BAUSCH HEALTH
  • BAXTER INTERNATIONAL INC.
  • BAYER AG
  • BEIGENE
  • BESPAK EUROPE
  • BIOMERIEUX
  • BIOSENSICS
  • BIOSERENITY
  • BIOTRICITY
  • BIOTRONIK
  • BIOVOTION
  • BIOXCEL THERAPEUTICS
  • BODYTEL
  • BOEHRINGER INGELHEIM
  • BOSTON SCIENTIFIC
  • BRAINMARC
  • BRISTOL-MYERS SQUIBB
  • BTS BIOENGINEERING
  • CARDIOMEMS INC. (ST. JUDEソ子會社)
  • CARMA LABORATORIES, INC.
  • CELGENE
  • CHATTEM INC.
  • CHUGAI PHARMACEUTICALS CO. LTD.
  • CILAG AG
  • CIPLA
  • CLEVELAND MEDICAL DEVICES
  • COLGATE-PALMOLIVE CO.
  • CONNECTEDHEALTH PTE. LTD.
  • CONSORT MEDICAL
  • CORBUS PHARMACEUTICALS
  • CSPC PHARMACEUTICAL GROUP
  • 第一三共
  • DERMA SCIENCES
  • DEXCOM INC.
  • DR. REDDY'S LABORATORIES LTD.
  • EARLYSENSE
  • Eisai
  • ELI LILLY AND CO.
  • EMPATICA
  • ENDO INTERNATIONAL
  • ENDOCEUTICS INC.
  • ENDOTRONIX
  • ENTRA HEALTH SYSTEMS
  • ERYTECH PHARMA
  • ESTEVE
  • EVERIST HEALTH
  • EYESCIENCE LABS
  • FERTIN PHARMA A/S
  • GABA SCHWEIZ
  • GALDERMA S.A.
  • GEMINI PHARMACEUTICALS INC.
  • GENOMMA LAB INTERNATIONAL
  • GENOMMA LAB USA
  • GILEAD SCIENCES
  • GLAXOSMITHKLINE PLC
  • GLOOKO INC.
  • GLUCOVISTA INC.
  • HEALTH CARE ORIGINALS
  • HIKMA PHARMACEUTICALS
  • 久光製藥
  • HOCOMA
  • IHEALTH LAB INC.
  • IMMUNOMEDICS
  • IMPACT SPORTS TECHNOLOGIES
  • IMPAK HEALTH
  • INFOBIONIC INC.
  • INSULET CORP.
  • INTELESENS
  • INTRA-CELLULAR THERAPIES
  • IOVANCE BIOTHERAPEUTICS
  • IPSEN S.A.
  • JAN MEDICAL INC.
  • JIANGSU HENGRUI MEDICINE
  • JOHNSON & JOHNSON
  • 興和
  • 協和發酵KIRIN
  • LAKE CONSUMER PRODUCTS INC.
  • LES LABORATOIRES SERVIER
  • LIVANOVA PLC
  • LUNDBECK
  • LUPIN
  • MALLINCKRODT PLC
  • MANX HEALTHCARE LTD.
  • MCM KLOSTERFRAU VERTRIEBS GMBH (KLOSTERFRAU HEALTHCARE GROUP)
  • MEDA AB
  • MEDMINDER
  • MEDTRONIC
  • MEDTRONIC MINIMED INC. (MEDTRONICソ子會社)
  • MELALEUCA INC.
  • MENARINI
  • MERCK
  • MERZ PHARMA
  • MIO GLOBAL
  • 田邊三菱製藥
  • 持田製藥
  • MYCARDIO LLC
  • MYLAN INC.
  • NEMAURA MEDICAL INC.
  • NEOFECT CO. LTD.
  • NEUROCRINE BIOSCIENCES
  • NEUROMETRIX INC.
  • NEUROVIGIL INC.
  • NEUTROGENA CORP.
  • NORTHEAST PHARMACEUTICAL GROUP CO. LTD.
  • NOVARTIS
  • NOVASOM INC.
  • NOVO NORDISK
  • NOW FOODS
  • NUCANA
  • OMADA HEALTH INC.
  • OMNICELL INC.
  • レу①⑦
  • 小野藥品工業
  • ORION PHARMA LTD.
  • ORPYX MEDICAL TECHNOLOGIES
  • 大塚製藥
  • PACIRA PHARMACEUTICALS INC.
  • PERRIGO PLC
  • PFIZER
  • PGT HEALTHCARE (PROCTER & GAMBLE的部門)
  • PHARMAVITE LLC
  • PHILOSYS
  • PIERRE FABRE PHARMACEUTICALS INC.
  • PIRAMAL HEALTHCARE LTD.
  • POLAR ELECTRO OY
  • PRESTIGE BRANDS HOLDINGS INC.
  • PREVENTICE INC.
  • PRIZM MEDICAL INC.
  • PROPELLER HEALTH
  • PROTEOSTASIS THERAPEUTICS
  • PROTEUS DIGITAL HEALTH INC.
  • QARDIO
  • RECKITT BENCKISER (NORTH AMERICA) INC.
  • RECKITT BENCKISER PLC.
  • RECORDATI PHARMA GMBH
  • REHAB-ROBOTICS (VINCENT MEDICAL HOLDINGS的成員)
  • REVOLYMER (U.K.) LTD
  • REXAHN PHARMACEUTICALS
  • ROCHE
  • SAGE PRODUCTS LLC
  • SAGE THERAPEUTICS
  • SANOFI
  • SAREPTA THERAPEUTICS
  • 佐籐製藥
  • SENSE4CARE
  • SENSEONICS HOLDINGS
  • SENTICARE INC.
  • SHAKLEE CORP.
  • SHANGHAI PHARMACEUTICALS HOLDING
  • 鹽野義製藥
  • SILVERGENS
  • SPROUTLING INC. (已經被MATTEL收購)
  • ST. JUDE MEDICAL (ABBOTT LABORATORIES的子公司)
  • STADA ARZNEIMITTEL AG
  • 大日本住友製藥
  • SUN PHARMACEUTICAL INDUSTRIES
  • SWISSE WELLNESS PTY LTD.
  • 大正製藥控股公司
  • 大正製藥
  • 武田藥品工業
  • TCR2 THERAPEUTICS
  • TEVA PHARMACEUTICAL INDUSTRIES
  • TISSO NATURPRODUKTE GMBH
  • TOWERVIEW HEALTH INC.
  • TRANSLATE BIO
  • TYME TECHNOLOGIES
  • UCB
  • UNILIFE CORP.
  • VAICA
  • VERTEX PHARMACEUTICAL
  • VITAL CONNECT
  • WELLSPRING PHARMACEUTICAL CORP.
  • WEST PHARMACEUTICAL SERVICES INC.
  • WINMEDICAL SRL
  • YBRAIN
  • YPSOMED HOLDING AG
  • ZEAVISION LLC
  • ZOGENIX INC.
  • ZYDUS CADILA

第14章 附錄A:略語一覽

第15章 附錄B:專門機構一覽

目錄
Product Code: HLC251A

Highlights:

The global market for OTC drugs, medical devices and diagnostics should grow from $259 billion in 2019 to $361 billion by 2024 at compound annual growth rate (CAGR) of 6.9% for the period of 2019-2024.

U.S. market for OTC drugs, medical devices and diagnostics should grow from $91 billion in 2019 to $128 billion by 2024 at a CAGR of 7.1% for the period of 2019-2024.

Asia-Pacific market for OTC drugs, medical devices and diagnostics should grow from $57 billion in 2019 to $83 billion by 2024 at a CAGR of 7.8% for the period of 2019-2024.

Report Scope:

This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for OTC drugs, medical devices and diagnostic kits used for self-care and the management of various common diseases.

The report considers only "Western" or modern drugs and excludes any other type of drugs such as alternative therapies. This report covers medical devices and diagnostic kits exempted by the U.S. FDA for OTC use.

This study aims to provide an understanding of the dynamics and forecasts of the OTC drugs, medical devices and diagnostic kits market worldwide and provides key market propositions over a five-year forecast period.

The report covers developed and emerging markets in order to help readers understand -

  • Detailed description, including demographics and cost burden, of various diseases including cardiovascular diseases, orthopedic diseases, respiratory disorders, diabetes, obesity, gastrointestinal disorders, sleep disorders, skin disorders, and ENT disorders.
  • Detailed description and analysis of current OTC drugs, medical devices and diagnostic kits.
  • Market characterization, unmet need, and market size and segmentation (by region, by segment, by diseases).
  • The current state of the market and the key markets for its future development.
  • Major regional trends.
  • Market drivers and restraints.
  • Detailed market projections through 2024.
  • Global competitive thrust in terms of competition and market shares.
  • Key marketed and pipeline (research and development) products along with information about their regulatory status.
  • Strategic landscape (mergers and acquisitions).
  • Regulatory structure: new regulations that will influence the development of the OTC drugs, devices and diagnostics market.
  • Pricing and reimbursement.
  • Observations and conclusions on the future of OTC drugs, medical devices and diagnostics.
  • Profiles of market participants and associations.

Report Includes:

  • 26 data tables and 22 additional tables
  • An overview of the global markets for over-the-counter (OTC) drugs, medical devices and diagnostics
  • Analyses of global market trends with data from 2018 and 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Coverage of various target diseases, including common health disorders and severe chronic diseases where OTC drugs and devices play a key role in the management of diseases
  • Assessment of the recent breakthroughs, current research activities, technological hurdles and latest trends related to the field of medical technologies
  • Complete understanding about the usage and adoption rate of OTC drugs, devices and diagnostic kits in various regions
  • Underlying details of key business opportunities to pivotal stakeholders to expand of business and capture the revenue in the specific verticals to analyze before investing or expanding the horizon within this market
  • Competitive landscape encompassing a large chunk of small, medium and large players on both pharmaceutical drugs and medical devices and diagnostics side
  • Profile description of leading market players, including 3M, Akron, Bayer AG, Celgene, and Eli Lilly and Co.

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Intended Audience
  • Methodology and Information Sources
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Target Diseases and Disorders

  • Overview of Common Diseases and Disorders for OTC
  • Cardiovascular Disease
  • Lifestyle Disorders
  • Respiratory Disorders
  • Musculoskeletal Disorders
  • Mental/Mood Disorders
  • Gastrointestinal Disorders
  • Urology Disorders
  • Chronic Wounds
  • Chronic Pain
  • Panic Disorder/Anxiety Disorder
  • ENT Disorders
  • Dental Disorders
  • Eating Disorders
  • Tobacco Smoking and Associated Diseases
  • Chronic Diseases: Expanding Horizon for OTC Market
  • Aging, Gender and Onset of Diseases
  • Global Demographics
  • U.S. Demographics
  • U.S.: Gender, Age and Life Expectancy
  • European Demographics
  • Japanese Demographics
  • Current Challenges and Future Directions

Chapter 4 OTC Drugs and Nutritional Supplements

  • OTC Therapeutics Overview
  • Evolution of OTC drugs
  • Clinical Need of Drugs
  • Drug-Based Disease Management
  • Generic Drugs and Disease Management
  • Generic Drugs vs. Branded Drugs
  • Continued Resistance to Generics
  • OTC Drugs and Types
  • OTC Analgesics/Antipyretics
  • OTC Antihistamine and Cough and Cold Drugs
  • OTC Gastrointestinal Products
  • OTC Dermatological Drugs
  • OTC Oral Medical Care Products
  • OTC Eye Care Products
  • OTC Smoking Cessation Products
  • Key Marketed OTC Drugs
  • OTC Dietary Supplements and Types
  • Eating Disorders
  • Treatments for Vitamin and Mineral Deficiency
  • Vitamin and Mineral Supplements (VMS)
  • Distribution Channel for OTC
  • Multinational OTC Drug Manufacturers
  • Drug Stores and Other Chain Store Brands
  • FMCGs
  • Practice of OTC Drug Purchase
  • Regulatory Influence on OTC Drug Market
  • Market Situation for OTC Drugs and Dietary Supplements
  • Well-Developed Markets
  • Developing Markets
  • Underdeveloped Markets
  • Therapeutics and Cost Burden
  • Unmet Need
  • Current Challenges and Future Developments

Chapter 5 OTC Medical Devices and Diagnostics

  • Medical Devices, Diagnostics and Disease Management
  • Clinical and Market Need of OTC Devices and Diagnostics
  • Types of OTC Devices and Diagnostics
  • Self-Care Devices and Wearables
  • Diagnostic Devices and Kits
  • Key Products
  • Diagnostic and Monitoring Devices
  • Therapeutic Devices and Technologies
  • Remote Patient Monitoring and Home Healthcare
  • Advantages of Disease Management via Digital Care
  • Unmet Need
  • Current Challenges
  • Future Outlook

Chapter 6 OTC Devices for Treatment Adherence

  • Treatment Nonadherence
  • Market Need for OTC Medication Adherence Devices
  • Hardware-Centric OTC Medication Adherence Devices
  • Smart Pill Bottle
  • Automated Pill Dispenser
  • Electronic Tray
  • Smart Caps
  • Other Adherence Devices and Solutions
  • Key Products
  • Smart Pill Dispensers, Pillboxes, Organizers, Smart Pill Cap and Bottle Systems
  • Other OTC Adherence Devices
  • Current Challenges
  • Future Developments

Chapter 7 Market Size and Growth Analysis

  • Market Size and Growth Analysis
  • Market Size and Growth Analysis, by Region
  • Market Size and Growth Analysis, by Product Segment
  • Market Size and Growth Analysis, by Disease Type
  • Market Growth Drivers and Restraints
  • Market Growth Drivers
  • Market Restraints
  • Regulatory Impact on the OTC Market
  • Brexit Effect on the OTC Market in Europe
  • SWOT Analysis of OTC Market

Chapter 8 Competitive Landscape in the OTC Drugs, Medical Devices and Diagnostics Market

  • Competitive Landscape: Disease Treatment and Management with OTC Drugs, Medical Devices and Diagnostic Technologies

Chapter 9 Strategies in the OTC Drugs, Medical Devices and Diagnostics Market

  • Consolidation in the OTC Drugs and Devices Market
  • Mergers and Acquisitions in the OTC Drugs, Medical Devices and Diagnostics Market
  • OTC Drugs and Nutritional Products (Vitamin and Mineral Supplements)
  • OTC Medical Devices and Diagnostics
  • Recent Mergers and Acquisitions
  • OTC Medical Devices and Diagnostics
  • OTC Drugs and Nutritional Products (Vitamin and Mineral Supplements)
  • Minority Stakes and Future Options to Acquire
  • Future Strategic Landscape

Chapter 10 Regulatory Structure: Pharmaceuticals, Medical Devices and Diagnostics

  • Regulatory Background
  • Regulatory Systems for Medical Devices, by Region
  • U.S.
  • European Union
  • Japan
  • Regulatory Systems for Pharmaceuticals, by Region
  • U.S.
  • Europe
  • Japan
  • Rules and Regulations for OTC Drugs and Dietary Supplements
  • Regulations for OTC drugs
  • Regulations for Dietary Supplements

Chapter 11 Pricing and Reimbursement: Pharmaceuticals, Medical Devices and Diagnostics

  • Pricing and Reimbursement Background
  • Pricing and Reimbursement for Medical Devices, by Region
  • U.S.
  • Europe
  • Japan
  • Other Asia-Pacific
  • Pricing and Reimbursement for Pharmaceuticals, by Region
  • U.S.
  • Europe
  • Japan

Chapter 12 Conclusions-Outlook for OTC Drugs, Medical Devices and Diagnostics

  • Major Developments Influencing the Market
  • Technological Developments
  • Demographic and Economic Trends
  • Changing Structure of the Healthcare Industry
  • Lifestyle Medicine
  • Patient-Centric Programs
  • Prevalence of Self-Care
  • Burden on Public Health System
  • Retain Market Leadership
  • Long-Term Outlook

Chapter 13 Company Profiles

  • 3M
  • ABBOTT LABORATORIES
  • ABBVIE INC.
  • ACADIA PHARMACEUTICAL
  • ACORDA THERAPEUTICS
  • ACTAVIS PLC
  • ACTUALMEDS
  • ADHERIUM
  • AETHLON MEDICAL INC.
  • AGENUS
  • AKRON
  • ALACER CORP.
  • ALCON INC.
  • ALERE INC.
  • ALFRESA PHARMA CORP.
  • ALIPHCOM INC.
  • ALIVECOR
  • ALKALON A/S
  • ALKERMES
  • ALLERGAN
  • ALLIANCE HEALTHCARE
  • AMGEN INC.
  • AMIKO
  • AMNEAL PHARMACEUTICALS
  • ANAVEX LIFE SCIENCES
  • ANI PHARMACEUTICALS
  • ANIMAS (A SUBSIDIARY OF JOHNSON & JOHNSON)
  • APOTEX
  • ARCHOS
  • ARENA PHARMACEUTICALS
  • ARRAY BIOPHARMA
  • ASAHI KASAI CORP.
  • ASLAN PHARMACEUTICALS
  • ASPEN PHARMACARE
  • ASSERTIO THERAPEUTICS, INC.
  • ASTELLAS PHARMA INC.
  • ASTRAZANECA PLC
  • ATHERSYS
  • AUDENTES THERAPEUTICS
  • AXIOBIONICS
  • AXSOME THERAPEUTICS
  • BAUSCH & LOMB
  • BAUSCH HEALTH
  • BAXTER INTERNATIONAL INC.
  • BAYER AG
  • BEIGENE
  • BESPAK EUROPE
  • BIOMERIEUX
  • BIOSENSICS
  • BIOSERENITY
  • BIOTRICITY
  • BIOTRONIK
  • BIOVOTION
  • BIOXCEL THERAPEUTICS
  • BODYTEL
  • BOEHRINGER INGELHEIM
  • BOSTON SCIENTIFIC
  • BRAINMARC
  • BRISTOL-MYERS SQUIBB
  • BTS BIOENGINEERING
  • CARDIOMEMS INC. (A SUBSIDIARY OF ST. JUDE)
  • CARMA LABORATORIES, INC.
  • CELGENE
  • CHATTEM INC.
  • CHUGAI PHARMACEUTICALS CO. LTD.
  • CILAG AG
  • CIPLA
  • CLEVELAND MEDICAL DEVICES
  • COLGATE-PALMOLIVE CO.
  • CONNECTEDHEALTH PTE. LTD.
  • CONSORT MEDICAL
  • CORBUS PHARMACEUTICALS
  • CSPC PHARMACEUTICAL GROUP
  • DAIICHI SANKYO
  • DERMA SCIENCES
  • DEXCOM INC.
  • DR. REDDY'S LABORATORIES LTD.
  • EARLYSENSE
  • EISAI
  • ELI LILLY AND CO.
  • EMPATICA
  • ENDO INTERNATIONAL
  • ENDOCEUTICS INC.
  • ENDOTRONIX
  • ENTRA HEALTH SYSTEMS
  • ERYTECH PHARMA
  • ESTEVE
  • EVERIST HEALTH
  • EYESCIENCE LABS
  • FERTIN PHARMA A/S
  • GABA SCHWEIZ
  • GALDERMA S.A.
  • GEMINI PHARMACEUTICALS INC.
  • GENOMMA LAB INTERNATIONAL
  • GENOMMA LAB USA
  • GILEAD SCIENCES
  • GLAXOSMITHKLINE PLC
  • GLOOKO INC.
  • GLUCOVISTA INC.
  • HEALTH CARE ORIGINALS
  • HIKMA PHARMACEUTICALS
  • HISAMITSU PHARMACEUTICAL CO. INC.
  • HOCOMA
  • IHEALTH LAB INC.
  • IMMUNOMEDICS
  • IMPACT SPORTS TECHNOLOGIES
  • IMPAK HEALTH
  • INFOBIONIC INC.
  • INSULET CORP.
  • INTELESENS
  • INTRA-CELLULAR THERAPIES
  • IOVANCE BIOTHERAPEUTICS
  • IPSEN S.A.
  • JAN MEDICAL INC.
  • JIANGSU HENGRUI MEDICINE
  • JOHNSON & JOHNSON
  • KOWA CO. LTD.
  • KYOWA HAKKO KIRIN
  • LAKE CONSUMER PRODUCTS INC.
  • LES LABORATOIRES SERVIER
  • LIVANOVA PLC
  • LUNDBECK
  • LUPIN
  • MALLINCKRODT PLC
  • MANX HEALTHCARE LTD.
  • MCM KLOSTERFRAU VERTRIEBS GMBH (KLOSTERFRAU HEALTHCARE GROUP)
  • MEDA AB
  • MEDMINDER
  • MEDTRONIC
  • MEDTRONIC MINIMED INC. (A SUBSIDIARY OF MEDTRONIC)
  • MELALEUCA INC.
  • MENARINI
  • MERCK
  • MERZ PHARMA
  • MIO GLOBAL
  • MITSUBISHI TANABE PHARMA
  • MOCHIDA PHARMACEUTICAL CO. LTD.
  • MYCARDIO LLC
  • MYLAN INC.
  • NEMAURA MEDICAL INC.
  • NEOFECT CO. LTD.
  • NEUROCRINE BIOSCIENCES
  • NEUROMETRIX INC.
  • NEUROVIGIL INC.
  • NEUTROGENA CORP.
  • NORTHEAST PHARMACEUTICAL GROUP CO. LTD.
  • NOVARTIS
  • NOVASOM INC.
  • NOVO NORDISK
  • NOW FOODS
  • NUCANA
  • OMADA HEALTH INC.
  • OMNICELL INC.
  • OMRON CORP.
  • ONO PHARMACEUTICAL CO. LTD.
  • ORION PHARMA LTD.
  • ORPYX MEDICAL TECHNOLOGIES
  • OTSUKA PHARMACEUTICALS
  • PACIRA PHARMACEUTICALS INC.
  • PERRIGO PLC
  • PFIZER
  • PGT HEALTHCARE (DIVISION OF PROCTER & GAMBLE)
  • PHARMAVITE LLC
  • PHILOSYS
  • PIERRE FABRE PHARMACEUTICALS INC.
  • PIRAMAL HEALTHCARE LTD.
  • POLAR ELECTRO OY
  • PRESTIGE BRANDS HOLDINGS INC.
  • PREVENTICE INC.
  • PRIZM MEDICAL INC.
  • PROPELLER HEALTH
  • PROTEOSTASIS THERAPEUTICS
  • PROTEUS DIGITAL HEALTH INC.
  • QARDIO
  • RECKITT BENCKISER (NORTH AMERICA) INC.
  • RECKITT BENCKISER PLC.
  • RECORDATI PHARMA GMBH
  • REHAB-ROBOTICS (A MEMBER OF VINCENT MEDICAL HOLDINGS)
  • REVOLYMER (U.K.) LTD
  • REXAHN PHARMACEUTICALS
  • ROCHE
  • SAGE PRODUCTS LLC
  • SAGE THERAPEUTICS
  • SANOFI
  • SAREPTA THERAPEUTICS
  • SATO PHARMACEUTICAL CO. LTD.
  • SENSE4CARE
  • SENSEONICS HOLDINGS
  • SENTICARE INC.
  • SHAKLEE CORP.
  • SHANGHAI PHARMACEUTICALS HOLDING
  • SHIONOGI AND CO. LTD.
  • SILVERGENS
  • SPROUTLING INC. (ACQUIRED BY MATTEL)
  • ST. JUDE MEDICAL (A SUBSIDIARY OF ABBOTT LABORATORIES)
  • STADA ARZNEIMITTEL AG
  • SUMITOMO DAINIPPON PHARMA CO. LTD.
  • SUN PHARMACEUTICAL INDUSTRIES
  • SWISSE WELLNESS PTY LTD.
  • TAISHO PHARMACEUTICAL HOLDINGS
  • TAISHO PHARMACEUTICAL
  • TAKEDA PHARMACEUTICAL CO. LTD.
  • TCR2 THERAPEUTICS
  • TEVA PHARMACEUTICAL INDUSTRIES
  • TISSO NATURPRODUKTE GMBH
  • TOWERVIEW HEALTH INC.
  • TRANSLATE BIO
  • TYME TECHNOLOGIES
  • UCB
  • UNILIFE CORP.
  • VAICA
  • VERTEX PHARMACEUTICAL
  • VITAL CONNECT
  • WELLSPRING PHARMACEUTICAL CORP.
  • WEST PHARMACEUTICAL SERVICES INC.
  • WINMEDICAL SRL
  • YBRAIN
  • YPSOMED HOLDING AG
  • ZEAVISION LLC
  • ZOGENIX INC.
  • ZYDUS CADILA

Chapter 14 Appendix A: List of Acronyms

Chapter 15 Appendix B: Professional Organizations

  • American Heart Association
  • Center for Drug Evaluation and Research (CDER)
  • Center for Devices and Radiological Health (CDRH)
  • Centers for Medicare and Medicaid Services (CMS)
  • European Databank for Medical Devices (EUDAMED)
  • Food and Drug Administration (FDA or U.S. FDA)
  • Hormone Foundation
  • International Diabetes Federation (IDF)
  • International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
  • Network for Excellence in Health Innovation (NEHI)
  • National Center for Biotechnology Information (NCBI)
  • National Institute of Aging (NIA)
  • Pharmaceuticals and Medical Devices Agency (PMDA)
  • World Cancer Research Fund International
  • World Health Organization (WHO)

List of Tables

  • Summary Table : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Country/Region, Through 2024
  • Table 1 : Global Incidence Share of Hypertension, by Patient Group Type, 2019
  • Table 2 : Global Prevalence of Angina Pectoris and Stroke (Survivors), Through 2030
  • Table 3 : Global Prevalence of Congestive Heart Failure and Stroke, Through 2030
  • Table 4 : Structural Heart Disease Management Through Medication
  • Table 5 : BMI Calculation
  • Table 6 : BMI Categories Based on Increasing Health Risks
  • Table 7 : Trends in Obesity Composition of the World's Population, Through 2025
  • Table 8 : Obesity and Severe Obesity vs. General Population in U.S., Through 2025
  • Table 9 : Global Share of Diabetes, by Type
  • Table 10 : Global Prevalence of Diabetes, by Type, Through 2040
  • Table 11 : Global Symptomatic Prevalence of Key Musculoskeletal Disorders, Through 2025
  • Table 12 : Global Deaths, by Various Musculoskeletal Disorders, Through 2030
  • Table 13 : Global Deaths from Digestive Diseases, by Region, Through 2025
  • Table 14 : Global Deaths Share, by Various Chronic Disease Types, 2018
  • Table 15 : Global DALYs Share, by Various Chronic Disease Types, 2018
  • Table 16 : Estimated World Population and Annual Growth, by Age Group, Through 2030
  • Table 17 : World Population, by Country/Region, Through 2030
  • Table 18 : U.S. Population Estimates and Projections, by Age Group, Through 2030
  • Table 19 : Estimates of Anticipated U.S. Life Expectancy at Birth, by Gender, Through 2020
  • Table 20 : European Population Estimates and Projections, by Age Group, Through 2030
  • Table 21 : Japanese Population Estimates and Projections, by Age Group, Through 2030
  • Table 22 : Key Marketed OTC Drugs
  • Table 23 : Cardiac Monitoring Devices and Technologies, by Company
  • Table 24 : Key Continuous Glucose Monitoring Devices and Technologies, by Company
  • Table 25 : Sleep-Monitoring Devices and Technologies, by Company
  • Table 26 : Key Vital Sign and Activity Monitoring Devices and Technologies, by Company
  • Table 27 : Pain Management Devices and Technologies, by Company
  • Table 28 : Drug Delivery Devices and Technologies, by Company
  • Table 29 : Insulin Delivery Devices and Technologies, by Company
  • Table 30 : Global Medication Adherence Percentages, by Chronic Diseases
  • Table 31 : Smart Pill Dispensers, Pillboxes and Organizers, by Company
  • Table 32 : Medication Tracking Devices and Apps, by Company
  • Table 33 : Pill Organizer and Reminder Systems, by Company
  • Table 34 : Smart Pill Cap and Bottle Systems, by Company
  • Table 35 : Other Medication Adherence Solutions, by Company
  • Table 36 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Country/Region, Through 2024
  • Table 37 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Product Segment, Through 2024
  • Table 38 : Global Market for OTC Treatment Adherence Devices, Through 2024
  • Table 39 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Disease Type, Through 2024
  • Table 40 : SWOT Analysis of the OTC Drugs, Medical Devices and Diagnostics Market
  • Table 41 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Company, 2019
  • Table 42 : Key Strategic Deals in the OTC Medical Devices and Diagnostics Market, by Company, 2012-2019
  • Table 43 : Key Strategic Deals in OTC Drugs and Nutritional Product/Supplement Market, by Company, 2016-2019
  • Table 44 : Key Strategic Deals for Business Units, Minority Stakes and Future Options to Acquire in the OTC Market, by Company, 2016-2019
  • Table 45 : Differences in Regulatory Approval in the U.S. and Europe
  • Table 46 : Trends in Per Capita Real Gross Domestic Product Growth, by Region, 2015-2018
  • Table 47 : List of Acronyms used in OTC Drugs, Medical Devices and Diagnostics

List of Figures

  • Summary Figure : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Country/Region, 2018-2024
  • Figure 1 : Global Incidence Share of Hypertension, by Patient Group Type, 2019
  • Figure 2 : Global Prevalence of Angina Pectoris and Stroke (Survivors), 2004-2030
  • Figure 3 : Global Prevalence of Congestive Heart Failure and Stroke, 2004-2030
  • Figure 4 : Trends in Obesity Composition of the World's Population, 2012-2025
  • Figure 5 : Obesity and Severe Obesity vs. General Population in U.S., 2018 and 2025
  • Figure 6 : Global Share of Diabetes, by Type
  • Figure 7 : Global Prevalence of Diabetes, by Type, 2018 and 2040
  • Figure 8 : Global Symptomatic Prevalence of Key Musculoskeletal Disorders, 2012-2025
  • Figure 9 : Global Deaths Share, by Various Musculoskeletal Disorders, 2015
  • Figure 10 : Global Deaths from Digestive Diseases, by Region, 2015-2025
  • Figure 11 : Global Deaths Share, by Various Chronic Disease Types, 2018
  • Figure 12 : Global DALYs Share, by Various Chronic Disease Types, 2018
  • Figure 13 : Estimated World Population and Annual Growth, by Age Group, 2000-2030
  • Figure 14 : World Population, by Country/Region, 2000-2030
  • Figure 15 : U.S. Population Estimates and Projections, by Age Group, 2000-2030
  • Figure 16 : Estimates of Anticipated U.S. Life Expectancy at Birth, by Gender, 2005-2020
  • Figure 17 : European Population Estimates and Projections, by Age Group, 2000-2030
  • Figure 18 : Japanese Population Estimates and Projections, by Age Group, 2000-2030
  • Figure 19 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Country/Region, 2018-2024
  • Figure 20 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Product Segment, 2018-2024
  • Figure 21 : Global Market Share for OTC Drugs, Medical Devices and Diagnostics, by Product Segment, 2019
  • Figure 22 : Global Market Share for OTC Drugs and Nutritional Supplements, by Therapeutic Classification, 2019
  • Figure 23 : Global Market Share for Device Technologies, by Device Type, 2019
  • Figure 24 : Global Market for OTC Treatment Adherence Devices, 2018-2024
  • Figure 25 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Disease Type, 2018-2024
  • Figure 26 : Trends in Per Capita Real Gross Domestic Product Growth, by Region, 2015-2018